Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies

Targeting CAPN9/CAPNS2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies

US Patent 11219670 · Granted Jan 11, 2022

Estimated economic value: $82,826,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Color card2025
Compositions and methods for treating vascular Ehlers Danlos syndrome and associ2024
Targeted epigenetic therapy against distal regulatory element of TGFβ2 expressio2023
Map kinase pathway targets for the treatment of Marfan syndrome2023
Methods for treating mendelian disorders of the epigenetic machinery2022
Targeted epigenetic therapy for inherited aortic aneurysm condition2022
Synthesis method of DHPV2022
Compositions and methods for treating kabuki syndrome and related disorders2020
Genetically encoded histone reporter allele constructs2019
Methods and compositons featuring TGF-beta antagonists for the treatment of marf2013
Delivery construct for antisense nucleic acids and methods of use2005
Mammalian regulator of nonsense-mediated RNA decay2000